Chief Executive Officer Founder
Lionel Comole is an experienced entrepreneur and executive with a strong track record in company creation, strategic development, and innovation financing in the life sciences sector. As CEO, he leads the company’s corporate strategy, financing activities, partnerships, and operational execution, driving the transition from academic discovery to clinical-stage development. Previously, Lionel held leadership positions across healthcare innovation ecosystems and contributed to the advancement of translational medicine initiatives.
Chief Scientific Officer
Dr. Valentin is an immunologist and biotech leader with extensive expertise in autoimmune diseases, translational immunology, and therapeutic innovation. As CSO, he oversees the scientific strategy and development of the company’s proprietary platform targeting pathogenic B- and T-cell clones involved in autoimmune diseases. Emmanuel has a proven track record of translating preclinical research into clinical applications through innovative immunotherapy programs and translational research collaborations.
Chief Technical Officer
Dr. Fontayne is a biotechnology and CMC expert specialized in bioprocess development, manufacturing scale-up, and pharmaceutical development for advanced therapies. As CTO, he leads technical operations, manufacturing strategy, CMC and industrialization activities supporting the company’s progression toward clinical development. Alexandre brings extensive expertise in process development, GMP manufacturing, and technology transfer across the biotech and pharmaceutical industries.